Relevant links

Gjelsvik YM, Myklebust TÅ, Fosså SD, Haug ES, Kvåle R, Ursin G, Johannesen TB (2025)
A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls
Qual Life Res (in press)
DOI 10.1007/s11136-025-04017-7, PubMed 40603678

Harba D, Corell A, Mansouri A, Brandal P, Blomstrand M, Jakola AS (2025)
A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points
Acta Neurochir (Wien), 167 (1), 196
DOI 10.1007/s00701-025-06612-6, PubMed 40682696

Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
Front Oncol, 15, 1397912
DOI 10.3389/fonc.2025.1397912, PubMed 39949738